Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.840 | 0.840 | 0.000 |
Stocks | 99.160 | 99.160 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.464 | 17.787 |
Price to Book | 5.837 | 3.193 |
Price to Sales | 2.808 | 1.963 |
Price to Cash Flow | 14.820 | 13.262 |
Dividend Yield | 2.778 | 2.924 |
5 Years Earnings Growth | 6.997 | 7.648 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 32.590 | 29.850 |
Industrials | 19.310 | 15.903 |
Consumer Defensive | 18.120 | 14.437 |
Financial Services | 11.640 | 20.114 |
Basic Materials | 11.080 | 8.064 |
Consumer Cyclical | 4.040 | 5.552 |
Technology | 3.220 | 4.133 |
Number of long holdings: 23
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 17.97 | 94.02 | -1.09% | |
Roche Holding Participation | CH0012032048 | 11.46 | 233.50 | +0.69% | |
Novartis | CH0012005267 | 10.28 | 93.41 | +0.27% | |
Zurich Insurance Group | CH0011075394 | 6.98 | 472.50 | +0.19% | |
Givaudan | CH0010645932 | 5.60 | 4,215.00 | +0.91% | |
Sika | CH0418792922 | 5.39 | 282.00 | +0.18% | |
ABB | CH0012221716 | 5.23 | 48.77 | +1.37% | |
Lonza Group | CH0013841017 | 4.65 | 514.40 | +0.74% | |
Partners Group | CH0024608827 | 4.56 | 1,249.00 | -1.03% | |
VAT Group | CH0311864901 | 3.96 | 492.60 | +3.57% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BCV PENSION 25 AP | 755.94M | 2.63 | -1.47 | 1.89 | ||
Synchrony All Caps CH I | 608.78M | 6.45 | 2.55 | 7.60 | ||
BCV PENSION 40 AP | 529.55M | 4.00 | -0.70 | 3.30 | ||
Synchrony Small Mid Caps CH I | 266.47M | 2.04 | -0.34 | 7.75 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review